Skip to content

Effectiveness of Unified Protocol in Anxiety Disorders

A PRELIMINARY EVALUATION OF UNIFIED PROTOCOL IN ANXIETY DISORDERS-A MULITPLE BASELINE STUDY

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030803
Enrollment
42
Registered
2021-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F400- Agoraphobia Health Condition 2: F411- Generalized anxiety disorder Health Condition 3: F413- Other mixed anxiety disorders Health Condition 4: F418- Other specified anxiety disorders Health Condition 5: F410- Panic disorder [episodic paroxysmal anxiety] Health Condition 6: F401- Social phobias

Interventions

Intervention1: Unified Protocol for emotional disorders: It is a transdiagnostic therapy for people with emotional disorders. In the current study, its effectiveness will be assessed in anxiety disord

Sponsors

University Grants Commission
Lead Sponsor
National Institute of Mental Health and Neuro Sciences
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with a primary diagnosis of anxiety disorder according to DSM-V People who consent for the baseline phase Patients who can comprehend and be conversant in English, Tamil or Malayalam Stabilized on medication 4 weeks prior to the beginning of the therapy

Exclusion criteria

Exclusion criteria: Primary diagnosis of schizophrenia, bipolar affective disorder, patients with suicidal risk, co-morbid severe depression with or without psychotic symptoms and clinical evidence for intellectual disability, or other neurological, neurosurgical or organic conditions that may interfere with engagement in therapy Current use of psychoactive substance in dependence pattern except nicotine dependence Primary diagnosis of depression with secondary anxiety symptoms Patients who have undergone structured psychotherapeutic intervention of 8 or more sessions will be excluded

Design outcomes

Primary

MeasureTime frame
Primary outcome: symptom severity (anxiety) Secondary outcome: anxiety sensitivity, intolerance to uncertainty, emotion regulationTimepoint: Primary outcome: Weekly assessment Secondary Outcome: Module wise assessment (approximately 2-4 sessions once)

Secondary

MeasureTime frame
anxiety sensitivity, intolerance to uncertainty, emotion regulationTimepoint: pre-treatment, module-wise assessment, post treatment and follow-up

Countries

India

Contacts

Public ContactB Arunya

National Institute of Mental Health and Neuro Sciences

paulomi.sudhir@gmail.com9886176879

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 10, 2026